At the department of Hematology we are dedicated to improving the diagnosis and treatment of patients with hematological diseases. We perform basic and translational research to generate insight into the pathobiology of hematological diseases, and translate these findings into novel treatments for our patients.
In addition, we direct a wide variety of clinical studies, closely linked to our preclinical programs. These clinical studies deal with the development of molecular diagnostics, advancement of allogeneic stem cell transplantation, circumvention of drug-resistance to chemotherapy as well as a broad range of clinical phase I to phase III trials for a variety of hematological diseases.
For more information on clinical care for patients with hematological diseases please see our clinical homepage.
Els Mansell from the Department of Hematology at Erasmus MC has been awarded an €850,000 Vidi grant from the Dutch Research Council (NWO). The five-year grant will support innovative research into the role of mitochondria in acute myeloid leukaemia (AML), with the long-term aim of developing new therapeutic strategies for this aggressive blood cancer.
The Erasmus MC Hematology Department is excited to announce it's new virtual lecture series!
On June 8 & 9th, the 9th workshop on “Molecular aspects of normal and malignant hematopoiesis” was held at KINO in Rotterdam. This workshop, organized by the Department of Hematology of the Erasmus MC, is intended for PhD students and postdocs from all hematology groups in Belgium and the Netherlands, so they can present their latest research and meet their colleagues.
On March 26 Lauren Pickott, PhD candidate in the group of Dr Ruben Bierings, won the Dr Jeanne Stibbe Award at the annual Nederlandse Vereniging voor Trombose en Hemostase (NVTH) symposium in Koudekerke for her presentation “Studying the involvement of BLOC-2 in trafficking to lysosome related organelles using a Hermansky-Pudlak Syndrome type 5 patient model”.
Ferdows Atiq has been awarded multiple prestigious international research grants to advance the understanding of the pathophysiology, diagnosis and management of von Willebrand disease (VWD).
On 24 March, Christian Vonk successfully defended his PhD thesis entitled ‘Advancing molecular measurable residual disease detection by next-generation sequencing in acute myeloid leukemia'.
The 2026-2027 digital lecture series starts on September 28th.
Everyone is invited to attend. Registration not necessary and attendance is free of charge.
If want to be updated on our lecture series and receive the links, subscribe to our newsletter here.
The 9th workshop on “Molecular aspects of hematological malignancies” will take place on 8 and 9 June, 2026 in Rotterdam. This meeting is meant to give young investigators (PhD's or Postdocs) a platform to present their most recent work. It is a perfect moment for young investigators in our field to meet and create their own network.
You can find more information on the workshop website.
